Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-22

Clinical Trial Update: 5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD) [EARLY_Phase 1]

View source ↗

Summary

A Baylor College of Medicine-sponsored EARLY Phase 1 trial evaluating 5-Azacytidine with steroids for gastrointestinal graft-versus-host disease has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Azacytidine (5-azacytidine)
  • Steroids (unspecified)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Graft-Versus-Host Disease(GVHD) | EARLY_Phase 1 | Status: WITHDRAWN